Volume 7, Issue 4, Pages 4-6
Background: To compare the safety & efficacy of Eberconazole and Terbinafine in patients of Tinea Versicolor. Subjects and Methods: 100 patients (58 males & 42 females) were selected and they were divided into two study groups. Group I patients were prescribed Terbinafine 1% cream for 15days and group II received Eberconazole 1% cream for15 days. Global clinical response assessment and visual analog scale was recorded in both groups. Results: There were 30 males and 22 females in group I and 28 males and 20 females in group II. in group I, 44 (88%) and in group II 39 (78%) showed complete healing. Mild residual disease was seen among 6 (12%) in group I and 10 (20%) in group II. Considerable residual disease was seen in 1 (2%) in group II only. A significant difference was observed between both groups (P< 0.05). The mean VAS score on baseline was 6.4 in group I and 7.0 in group II, on 7th day was 4.3 in group I and 5.4 in group II and on 15th day was 2.1 in group I and 2.9 in group II. Intergroup comparison showed non- significant difference (P> 0.05). Conclusion: Both Eberconazole & Terbinafine drugs were effective in management of cases of Tinea Versicolor. Eberconazole, a newer azole can be a new addition in the armamentarium for the treatment of tinea versicolor.
Eberconazole, Global clinical response, Tinea versicolor, Terbinafine.
Received 01 October 2018
Accepted 01 November 2018
It is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits authors to retain ownership of the copyright for their content, and allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. https://creativecommons.org/licenses/by/4.0/
Asian Journal of Medical Research (AJMR) is an international, peer-reviewed, quarterly open-access journal publishing advanced research across medical specialties.